journal article·2018-09-12

Combining Adhesive Nanostructured Surfaces and Costimulatory Signals to Increase T Cell Activation

Judith Guasch, Marco Hoffmann, Jennifer Diemer, Hossein Riahinezhad, Stefanie Neubauer, Horst Kessler, Joachim P. Spatz

Nano Letters· Volume 18· Issue 9
Publisher page

Abstract

Adoptive cell therapies are showing very promising results in the fight against cancer. However, these therapies are expensive and technically challenging in part due to the need of a large number of specific T cells, which must be activated and expanded in vitro. Here we describe a method to activate primary human T cells using a combination of nanostructured surfaces functionalized with the stimulating anti-CD3 antibody and the peptidic sequence arginine-glycine-aspartic acid, as well as costimulatory agents (anti-CD28 antibody and a cocktail of phorbol 12-myristate 13-acetate, ionomycin, and protein transport inhibitors). Thus, we propose a method that combines nanotechnology with cell biology procedures to efficiently produce T cells in the laboratory, challenging the current state-of-the-art expansion methodologies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: CAR-T cell therapy research · Monoclonal and Polyclonal Antibodies Research · Nanofabrication and Lithography Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Dynamic Biomaterials for Cancer Immunotherapy, Max Planck Partner Group, Institute of Materials Science of Barcelona (ICMAB-CSIC), Campus UAB, E-08193 Bellaterra, Spain

Department of Molecular Nanoscience and Organic Materials, ICMAB-CSIC and Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Campus UAB, E-08193 Bellaterra, Spain

Department of Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstrasse 29, D-69120 Heidelberg, Germany

Department of Biophysical Chemistry, University of Heidelberg, Im Neuenheimer Feld 253, D-69120 Heidelberg, Germany

Institute for Advanced Study (IAS) and Center of Integrated Protein Science (CIPSM), Department Chemie, Technische Universität München, Lichtenbergstrasse 4, D-85747 Garching, Germany

Funding

FP7 People: Marie-Curie Actions · Ministerio de Econom?a y Competitividad · Ag?ncia per a la Competitivitat de l?Empresa · Max-Planck-Gesellschaft · Max Planck Institute for Medical Research

References (46)

Show source-provided references
1. 10.1126/scitranslmed.300284210.1126/scitranslmed.3002842 ↗
2. 10.1056/NEJMoa110384910.1056/NEJMoa1103849 ↗
3. 10.1126/scitranslmed.aac541510.1126/scitranslmed.aac5415 ↗
4. 10.1111/imr.1213510.1111/imr.12135 ↗
5. 10.1111/imr.1212910.1111/imr.12129 ↗
6. 10.1021/acsomega.8b0052110.1021/acsomega.8b00521 ↗
7. 10.1038/nature0765710.1038/nature07657 ↗
8. 10.1016/0167-5699(90)90085-N10.1016/0167-5699(90)90085-N ↗
9. 10.1084/jem.173.3.75910.1084/jem.173.3.759 ↗
10. Levine B. L. · J. Immunol. · 1997 · 159 · 592110.4049/jimmunol.159.12.5921 ↗
11. Curtsinger J. M. · J. Immunol. · 1999 · 162 · 325610.4049/jimmunol.162.6.3256 ↗
12. 10.1021/nl403252x10.1021/nl403252x ↗
13. 10.1021/nl403266t10.1021/nl403266t ↗
14. 10.1021/nl402262310.1021/nl4022623 ↗
15. 10.1021/acs.nanolett.7b0263610.1021/acs.nanolett.7b02636 ↗
16. 10.1002/cbic.20050004110.1002/cbic.200500041 ↗
17. 10.3389/fimmu.2016.0000610.3389/fimmu.2016.00006 ↗
18. 10.1038/nri95910.1038/nri959 ↗
19. Chatila T. · J. Immunol. · 1989 · 143 · 128310.4049/jimmunol.143.4.1283 ↗
20. 10.1111/j.1432-1033.1990.tb15478.x10.1111/j.1432-1033.1990.tb15478.x ↗
21. 10.1111/j.1365-3083.1991.tb01787.x10.1111/j.1365-3083.1991.tb01787.x ↗
22. 10.1016/0092-8674(91)90517-310.1016/0092-8674(91)90517-3 ↗
23. 10.1083/jcb.116.5.107110.1083/jcb.116.5.1071 ↗
24. 10.1016/0304-4157(90)90008-Z10.1016/0304-4157(90)90008-Z ↗
25. 10.1529/biophysj.106.08973010.1529/biophysj.106.089730 ↗
26. 10.1021/acs.chemmater.5b0491010.1021/acs.chemmater.5b04910 ↗
27. 10.1021/ja960372110.1021/ja9603721 ↗
28. 10.1038/srep3980510.1038/srep39805 ↗
29. Davis L. S. · J. Immunol. · 1990 · 145 · 78510.4049/jimmunol.145.3.785 ↗
30. 10.1016/j.bbamcr.2006.09.02610.1016/j.bbamcr.2006.09.026 ↗
31. 10.1021/la990070n10.1021/la990070n ↗
32. 10.1116/1.353683910.1116/1.3536839 ↗
33. 10.1038/309030a010.1038/309030a0 ↗
34. 10.1002/chem.20130147810.1002/chem.201301478 ↗
35. 10.1002/adma.20150090010.1002/adma.201500900 ↗
36. 10.1021/acsnano.7b0606310.1021/acsnano.7b06063 ↗
37. 10.1002/adma.20170014510.1002/adma.201700145 ↗
38. 10.1016/S0065-2776(08)60029-210.1016/S0065-2776(08)60029-2 ↗
39. 10.1126/science.126004410.1126/science.1260044 ↗
40. 10.1002/jlb.65.5.70710.1002/jlb.65.5.707 ↗
41. 10.1038/nature0460610.1038/nature04606 ↗
42. 10.1021/acsnano.8b0328510.1021/acsnano.8b03285 ↗
43. 10.1002/adma.20160552910.1002/adma.201605529 ↗
44. 10.1016/0140-6736(93)92385-710.1016/0140-6736(93)92385-7 ↗
45. 10.1146/annurev-immunol-030409-10121210.1146/annurev-immunol-030409-101212 ↗
46. 10.1182/blood-2010-05-28628610.1182/blood-2010-05-286286 ↗